Cellular immune response induced by ubiquitin and Ag85A antigen fusion gene DNA vaccine in mice
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF NAUTICAL MEDICINE AND HYPERBARIC MEDICINE
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1009-6906.2010.05.014
- Key Word:
- 结核分支杆菌;Ag85A抗原;DNA疫苗;泛素;免疫应答;Mycobacterium tuberculosis;Ag85A antigen;DNA vaccine;Ubiquitin;Immune response
Abstract： Objective To evaluate the immune response induced by ubiquitin-Ag85A fused DNA vaccines (pUA). Methods Constructed DNA vaccines were intramuscularly inoculated into female BALB/c mice respectively. Serum antibodies (including IgG,IgG1,IgG2a),cytokines (IFN-γ,IL-4) and cytotoxic T lymphocyte response were detected in mice. The immune response intensity induced by fusion gene DNA vaccine and monogenic DNA vaccine was also compared. Results IgG level in the pA group was higher than that in the pUA group(P ＜0. 01 ),nevertheless,the ratio of IgG2a/IgG1 in the pA group was lower than that of the pUA group[(4. 16 ±0. 20)vs (7. 88 ± 0. 30 ),P ＜ 0. 01 ]. IFN-γ level increased (P ＜ 0. 01 ) and the IL-4 level decreased (P ＜ 0. 01 ) in the pUA group,when compared with those of the pA group. Furthermore,Ubiquitin fusion DNA vaccine enhanced the activity of CTL. Conclusions Results showed that humoral immune response induced by the fusion gene DNA vaccines was weaker than that by the monogenic DNA vaocine,however,stronger cellular immune response could be induced,when compared with the non-fusion DNA vaccine. Our study indicated that the ubiquitin fused DNA vaccine was more effective than the monogenic DNA vaccine in the prevention and treatment of tuberculosis.
- [1]康林,王庆敏,胡振林,等.稳定表达结核分枝杆菌38抗原的EL-4细胞株的建立及鉴定[J].2003,(11).
- [2]王庆敏,胡振林,周凤娟,等.ESAT6抗原DNA疫苗在小鼠体内诱导的免疫应答[J].2004,(6).
- [3]曾年华,王志斌,李兴国,等.南方部队肺结核危险因素的病例对照研究[J].2001,(3).
- [4]Zabolotnyh N,Romanova J,Kiselev O,etc.Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.[J].2006,13(8).
- [5]S L, Baldwin,C, D'Souza,A D, Roberts,etc.Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.[J].1998,66.
- [6]张习坦,韩光红,马静.试论军队传染病的流行趋势及对策[J].1997,(3).
- [7]Zhang J.,Whitton JL.,Rodriguez F..Dna Immunization - Ubiquitination of a Viral Protein Enhances Cytotoxic T-Lymphocyte Induction and Antiviral Protection but Abrogates Antibody Induction[J].1997,71(11).
- [8]P W, Roche,J A, Triccas,N, Winter.BCG vaccination against tuberculosis: past disappointments and future hopes.[J].1995,3(10).
- [9]P J, Cardona,A, Cooper,M, Luquín,etc.The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity.[J].1999,49(4).
- [10]Tong-Ming Fu,Liming Guan,Arthur Friedman,etc.Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens[J].1998,16(18).
- [11]Udagawa T,Taniyama T,Sugawara I.Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.[J].2007,87(2).
- [12]Alexander Varshavsky.The N-end rule: Functions, mysteries, uses[J].1996,93(22).
- [13]Peter Andersen,T. Mark Doherty.The success and failure of BCG - implications for a novel tuberculosis vaccine[J].2005,3(8).